Liver-targeting drugs and their effect on blood glucose and hepatic lipids
Who should not take GLP-1s GLP-1s in all forms are unsuitable for people who: are pregnant or breastfeeding do not meet the eligibility criteria have a family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) Medical Perspective Patients with needle phobia, a preference for pill-based routines, or good adherence to oral administration guidelines may be better suited to oral GLP-1 formulations like semaglutide (Rybelsus, Wegovy), which can enhance treatment acceptance and potentially offer strong glycemic or weight control
You should not take a GLP-1 if you are currently pregnant or breastfeeding
Exenatide extended-release (ER) , taken weekly: FDA-approved under the brand name Bydureon to treat type 2 diabetes
Grass-fed beef has the benefit of improved animal welfare, and meat raised without antibiotics or growth hormones can help slow antimicrobial resistance in humans and animals
It signals the pancreas to release insulin, helps cells absorb glucose, slows down how quickly food leaves the stomach, and sends signals to the brain to reduce appetite